Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Patient Safety and Risk Management
PS-074
HEALTHCARE ASSOCIATED INFECTIONS IN LONG-TERM CARE FACILITIES IN ASTI (ITALY)
PS-072
PRESCRIBING DEFICIENCIES: A MATTER OF LACK OF KNOWLEDGE OR NEGLIGENCE?
PS-071
TELAPREVIR-INDUCED STEVENS-JOHNSON SYNDROME. A CASE REPORT
PS-068
ANALYSIS OF PHARMACY INTERVENTIONS ON ANTIBIOTIC PRESCRIPTIONS IN MEDICAL PATIENTS
PS-065
RESULTS OF PHARMACEUTICAL INTERVENTIONS AT A HOSPITAL EMERGENCY DEPARTMENT
PS-055
MEDICINES RECONCILIATION STUDY AT THE EMERGENCY DEPARTMENT
PS-053
SYSTEM FOR IMPROVING ADHERENCE IN POLYMEDICATED PATIENTS
PS-051
RISKS RELATED TO DRUG RECALLS: A CASE REPORT
PS-047
CO-PRESCRIPTION OF SIMVASTATIN AND POTENT INHIBITORS OF CYP3A4; MONITORING SYSTEM IN HOSPITAL
PS-046
REDUCING ERRORS IN PHARMACEUTICAL CALCULATIONS – EDUCATING & TRAINING MEDICAL STAFF
PS-045
ADVERSE DRUG EVENTS IN THE PRESCRIBING PROCESS
PS-044
STREAMLINING MEDICINES ERROR REPORTING FUNCTIONALITY WITHIN A CLINICAL PHARMACY INTERVENTION PROGRAM
PS-042
SAFETY PROFILE OF AMIODARONE AND DRONEDARONE IN PATIENTS TREATED WITH ORAL VITAMIN K ANTAGONISTS
PS-040
PHARMACEUTICAL EVALUATION OF DRUG DOSAGE ADJUSTMENT ACCORDING TO RENAL FUNCTION
PS-038
REVIEW OF DRUG PRESCRIPTION ERRORS REPORTED TO THE HEALTH DEPARTMENT OF THE MADRID AUTONOMOUS COMMUNITY
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »
Follow Us